Pharmacokinetics of Chlorproguanil in Man after a Single Oral Dose of Lapudrine®
Authors:
- Michael D. EdsteinMEMichael D. Edstein
- Karl H. RieckmannKRKarl H. Rieckmann
- 1 January 1988
- journal article
- research article
- Published by S. Karger AG in Chemotherapy
- Vol. 34 (4) , 277-283
Abstract
The pharmacokinetic parameters of chlorproguanil (Lapudrine) and its active metabolite, chlorcycloguanil, were determined in 6 healthy male volunteers after a single oral dose of 4 Lapudrine tables (80 mg). The mean maximum plasma chlorproguanil concentration was 36.7 +/- (SD) 7.9 ng/ml and was reached at 3.8 +/- 1.3 h. The chlorproguanil elimination half-life was 17.5 +/- 6.7 h and its plasma clearance was 1.28 +/- 0.12 l/h/kg. The mean whole blood to plasma ratio was 3.1 at 4 h after dosing. Chlorcycloguanil could not be quantified in plasma and whole blood at the detection limit of 10 ng/ml using a high-performance liquid chromatographic method. An excretion rate-time plot from urine data shows a rapid (t1/2 = 20 h) and a slow phase (t1/2 = 51 h) in the elimination of chlorcycloguanil. Our findings suggest that the current prophylactic regimen of chlorproguanil hydrochloride (20 mg weekly) may not be optimal in preventing infections with chloroquine-resistant falciparum malaria.Keywords
This publication has 5 references indexed in Scilit:
- A preliminary pharmacokinetic study of the antimalarial drugs, proguanil and chlorproguanilJournal of Pharmacy and Pharmacology, 1987
- INADEQUACY OF CHLORPROGUANIL 20 mg PER WEEK AS CHEMOPROPHYLAXIS FOR FALCIPARUM MALARIA IN KENYAThe Lancet, 1987
- MALARIA CONTROL BY CHLORPROGUANIL .1. CLINICAL EFFECTS AND SUSCEPTIBILITY OF PLASMODIUM-FALCIPARUM INVIVO AFTER 7 YEARS OF MONTHLY CHLORPROGUANIL ADMINISTRATION TO CHILDREN IN A LIBERIAN VILLAGE1985
- Antimalarial Activity and Metabolism of BiguanidesThe American Journal of Tropical Medicine and Hygiene, 1961
- The Absorption and Excretion of Paludrine in the Human SubjectPathogens and Global Health, 1946